ProKidney Corp (NASDAQ: PROK) on Tuesday, soared 15.79% from the previous trading day, before settling in for the closing price of $0.75. Within the past 52 weeks, PROK’s price has moved between $0.46 and $4.44.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 6.93%. With a float of $91.19 million, this company’s outstanding shares have now reached $129.54 million.
The extent of productivity of a business whose workforce counts for 204 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of -241678.95%, and the pretax margin is -215701.32%.
ProKidney Corp (PROK) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of ProKidney Corp is 29.60%, while institutional ownership is 41.44%. The most recent insider transaction that took place on Apr 22 ’25, was worth 276,366. In this transaction Add’l Rep. Persons-see Ex.99-1 of this company bought 387,393 shares at a rate of $0.71, taking the stock ownership to the 73,842,723 shares. Before that another transaction happened on Apr 17 ’25, when Company’s Add’l Rep. Persons-see Ex.99-1 bought 25,000 for $0.75, making the entire transaction worth $18,690. This insider now owns 73,455,330 shares in total.
ProKidney Corp (PROK) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 6.93% per share during the next fiscal year.
ProKidney Corp (NASDAQ: PROK) Trading Performance Indicators
ProKidney Corp (PROK) is currently performing well based on its current performance indicators. A quick ratio of 10.96 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 819.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.60, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.59 in one year’s time.
Technical Analysis of ProKidney Corp (PROK)
The latest stats from [ProKidney Corp, PROK] show that its last 5-days average volume of 0.56 million was inferior to 0.7 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 42.66%. Additionally, its Average True Range was 0.13.
During the past 100 days, ProKidney Corp’s (PROK) raw stochastic average was set at 28.15%, which indicates a significant decrease from 51.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 137.08% in the past 14 days, which was higher than the 109.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8585, while its 200-day Moving Average is $1.6271. Now, the first resistance to watch is $0.9053. This is followed by the second major resistance level at $0.9421. The third major resistance level sits at $1.0148. If the price goes on to break the first support level at $0.7958, it is likely to go to the next support level at $0.7231. Assuming the price breaks the second support level, the third support level stands at $0.6863.
ProKidney Corp (NASDAQ: PROK) Key Stats
Market capitalization of the company is 254.17 million based on 292,698K outstanding shares. Right now, sales total 80 K and income totals -61,190 K. The company made 80 K in profit during its latest quarter, and -21,280 K in sales during its previous quarter.
